Eleen Rothschedl on Muck Rack

Eleen Rothschedl

As seen in: European Journal of Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Eleen

Contact Eleen, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Publicly accessible evidence of health-related quality of life benefits associated with cancer drugs approved by the European Medicines Agency between 2009 and 2015

|
By Nicole Grössmann, Martin Robausch, St. Pölten, Eleen Rothschedl
| European Journal of Cancer Verified
1. Introduction Cancer drugs should be clinically meaningful and thus not only prolong but also improve (or at least not worsen) patients' quality of life [1x[1]Kleijnen, S., Leonardo Alves, T., Meijboom, K., Lipska, I., De Boer, A., Leufkens, H.G. et al. The impact of quality-of-life data in relative effectiveness assessments of new anti-cancer drugs in European countries. Qual Life Res : Int J Qual Life Aspect Treat Care Rehabil.
Open in Who Shared Issue with article?
See all 1 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified